Professional Documents
Culture Documents
Art 3A10.1007 2Fs10103 011 0957 3
Art 3A10.1007 2Fs10103 011 0957 3
Art 3A10.1007 2Fs10103 011 0957 3
DOI 10.1007/s10103-011-0957-3
ORIGINAL ARTICLE
Red (660 nm) and infrared (830 nm) low-level laser therapy
in skeletal muscle fatigue in humans: what is better?
Patrcia de Almeida & Rodrigo lvaro Brando Lopes-Martins & Thiago De Marchi &
Shaiane Silva Tomazoni & Regiane Albertini & Joo Carlos Ferrari Corra &
Rafael Paolo Rossi & Guilherme Pinheiro Machado & Daniela Perin da Silva &
Jan Magnus Bjordal & Ernesto Cesar Pinto Leal Junior
Received: 9 March 2011 / Accepted: 24 June 2011 / Published online: 22 July 2011
# The Author(s) 2011. This article is published with open access at Springerlink.com
J. M. Bjordal
Section for Physiotherapy Science,
Department of Public Health and Primary Health Care,
Faculty of Medicine and Dentistry, University of Bergen,
Bergen, Norway
Introduction
In strenuous physical activity, muscles typically show a
progressive decline in performance which largely recovers
after a period of rest. This reversible phenomenon is usually
J. M. Bjordal
Centre for Evidence-Based Practice,
Bergen University College,
Bergen, Norway
454
A
B
C
Session
1
Red
Infrared
Placebo
Infrared
Placebo
Red
Placebo
Red
Infrared
455
The outcomes analyzed were the mean peak force and the
mean average force achieved during the fatigue protocol
in three exercise sessions. Data are expressed as means
and their respective standard deviations. ANOVA with the
Tukey-Kramer post test was used to determine if there
were significant differences in peak force and average
force following treatment with the red, infrared and
placebo LLLT. All statistical analyses were performed
using GraphPad InStat version 3.00 for Windows (GraphPad Software, San Diego CA). The significance level was
set at p<0.05.
Results
Ten untrained healthy male students met the inclusion
criteria and were included in study. Their average age was
6602
8302
Continuous
50
0.06
0.0028
17.85
5
1,785
100
4
20
Probe held stationary in skin contact
at 90 with slight pressure
456
Fig. 2 Mean peak forces achieved in the exercise protocol (error bars
represents standard deviations). *p<0.05, **p<0.01, vs. placebo
Discussion
In this trial we employed an isometric exercise protocol in
contrast to the repeated elbow flexions exercise protocol
employed in our previous human trials [2831]. This is the
first time that we have compared the effects of LLLT at two
wavelengths on skeletal muscle fatigue in humans. Red
LLLT (660 nm) significantly increased peak force by
12.14% (p<0.05) and mean average force by 13.09% (p<
0.05) compared to placebo LLLT. We have previously
reported positive effects of red LLLT (655 nm) in delaying
the development of skeletal muscle fatigue during an elbow
flexion exercise protocol performed by male professional
volleyball players [28].
The peak force and the average force were significantly
greater (14.49% and 13.24%, respectively) following
457
Conclusion
We conclude that both red and infrared LLLT are effective in
delaying the development of skeletal muscle fatigue and in
enhancing skeletal muscle performance. The optimal
parameters of application, as well as doseresponse patterns
for several wavelengths still need to be identified in further
studies. Further studies are also needed to identify the
specific mechanisms by which each wavelength acts.
Acknowledgement The authors would like to thank Fundo de
Apoio a Pesquisa (FAP/UNINOVE) for financial support.
Ethical standards This research was carried out in accordance with
current Brazilian laws relating to experiments in humans.
References
1. Allen DG, Lamb GD, Westerblad H (2008) Skeletal muscle
fatigue: cellular mechanisms. Physiol Rev 88:287332
2. Weir JP, Beck TW, Cramer JT, Housh TJ (2006) Is fatigue all in
your head? A critical review of the central governor model. Br J
Sports Med 40:573586
3. Goldman JA, Chiapella J, Casey H et al (1980) Laser therapy of
rheumatoid arthritis. Lasers Surg Med 1:93101
458
4. Hegedus B, Viharos L, Gervain M, Glfi M (2009) The effect of
low-level laser in knee osteoarthritis: a double-blind, randomized,
placebo-controlled trial. Photomed Laser Surg 27:577584
5. Bjordal JM, Lopes-Martins RA, Iversen VV (2006) A randomised,
placebo controlled trial of low level laser therapy for activated
achilles tendinitis with microdialysis measurement of peritendinous
prostaglandin E2 concentrations. Br J Sports Med 40:7680
6. Stergioulas A, Stergioula M, Aarskog R, Lopes-Martins RA,
Bjordal JM (2008) Effects of low-level laser therapy and eccentric
exercises in the treatment of recreational athletes with chronic
achilles tendinopathy. Am J Sports Med 36:881887
7. Ozcelik O, Cenk Haytac M, Kunin A, Seydaoglu G (2008)
Improved wound healing by low-level laser irradiation after
gingivectomy operations: a controlled clinical pilot study. J Clin
Periodontol 35:250254
8. Schubert MM, Eduardo FP, Guthrie KA et al (2007) A phase III
randomized double-blind placebo-controlled clinical trial to
determine the efficacy of low level laser therapy for the prevention
of oral mucositis in patients undergoing hematopoietic cell
transplantation. Support Care Cancer 15:11451154
9. Basford JR, Sheffield CG, Harmsen WS (1999) Laser therapy: a
randomized, controlled trial of the effects of low-intensity Nd:
YAG laser irradiation on musculoskeletal back pain. Arch Phys
Med Rehabil 80:647652
10. Gur A, Sarac AJ, Cevik R, Altindag O, Sarac S (2004) Efficacy of
904 nm gallium arsenide low level laser therapy in the management
of chronic myofascial pain in the neck: a double-blind and
randomize-controlled trial. Lasers Surg Med 35:229235
11. Chow RT, Heller GZ, Barnsley L (2006) The effect of 300 mW,
830 nm laser on chronic neck pain: a double-blind, randomized,
placebo-controlled study. Pain 124:201210
12. Chow RT, Johnson MI, Lopes-Martins RA, Bjordal JM (2009)
Efficacy of low-level laser therapy in the management of neck
pain: a systematic review and meta-analysis of randomised
placebo or active-treatment controlled trials. Lancet 374:1897
1908
13. Rochkind S, Leider-Trejo L, Nissan M, Shamir MH, Kharenko O,
Alon M (2007) Efficacy of 780-nm laser phototherapy on
peripheral nerve regeneration after neurotube reconstruction
procedure (double-blind randomized study). Photomed Laser Surg
25:137143
14. Lampl Y, Zivin JA, Fisher M et al (2007) Infrared laser therapy for
ischemic stroke: a new treatment strategy: results of the NeuroThera
Effectiveness and Safety Trial-1 (NEST-1). Stroke 38:18431849
15. Tullberg M, Alstergren PJ, Ernberg MM (2003) Effects of lowpower laser exposure on masseter muscle pain and microcirculation. Pain 105:8996
16. Silveira PC, Silva LA, Fraga DB, Freitas TP, Streck EL, Pinho R
(2009) Evaluation of mitochondrial respiratory chain activity in
muscle healing by low-level laser therapy. J Photochem Photobiol
B 95:8992
17. Xu X, Zhao X, Liu TC, Pan H (2008) Low-intensity laser irradiation
improves the mitochondrial dysfunction of C2C12 induced by
electrical stimulation. Photomed Laser Surg 26:197202
18. Avni D, Levkovitz S, Maltz L, Oron U (2005) Protection of
skeletal muscles from ischemic injury: low-level laser therapy
increases antioxidant activity. Photomed Laser Surg 23:273277
19. Rizzi CF, Mauriz JL, Freitas Correa DS et al (2006) Effects of
low-level laser therapy (LLLT) on the nuclear factor (NF)-kappaB
signaling pathway in traumatized muscle. Lasers Surg Med
38:704713
20. Albertini R, Aimbire FS, Correa FI et al (2004) Effects of different
protocol doses of low power gallium-aluminum-arsenate (Ga-Al-As)
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.